STERIS PLC (STE) Stock News
NYSE:STE - New York Stock Exchange, Inc. - IE00BFY8C754 - Common Stock - Currency: USD
STE Latest News, Press Relases and Analysis
What's going on in today's session: S&P500 movers
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Thursday as we examine the latest happenings in today's session.
What's going on in today's session: S&P500 movers
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Thursday.
Jefferies Initiates Coverage of Steris (STE) with ‘Hold’ Rating and $263 Price Target
Jefferies initiated coverage of Steris PLC (NYSE:STE) on May 28 with a ‘Hold’ rating and a $263 price target. The research firm reiterated that the company could come under pressure due to the risk of over 14 million Medicaid and Health Insurance individuals losing coverage. Jefferies expects STERIS to grow revenue by 8% in 2026, […]
Alcon Stock Rises Following the FDA Approval of TRYPTYR
FDA approves ALC's TRYPTYR, a new dry eye treatment with rapid tear production. The approval is supported by strong Phase 3 trial results.
This Sun Communities Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday
Mentions: SUI
Abbott Stock Gains Following FDA Approval of the Tendyne System
ABT wins FDA approval for its Tendyne TMVR system, offering a minimally invasive mitral valve replacement for high-risk patients with severe MAC.
Prestige Consumer Gains 35.7% in a Year: What's Driving the Stock?
PBH stock jumps on the back of brand strength, e-commerce gains and smart acquisitions despite tariff and foreign exchange headwinds.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
QGEN Stock Might Gain Following New Partnership With ID Solutions
QGEN teams up with ID Solutions to boost QIAcuity's reach in oncology dPCR assays, aiming to strengthen its cancer research leadership.
Walgreens Opens New Micro-Fulfillment Center in Brooklyn Park
WBA expands micro-fulfillment with a new facility in Brooklyn Park, MN. This will support nearly 200 Walgreens stores across the Midwest.
Are Options Traders Betting on a Big Move in STERIS (STE) Stock?
Investors need to pay close attention to STERIS (STE) stock based on the movements in the options market lately.
AST Business Growth & Strategic Acquisitions Support STERIS Stock
STE frequently engages in strategic acquisitions and joint ventures to optimize its portfolio of businesses.
Is it the Right Time to Hold STERIS Stock in Your Portfolio?
STE stays on investors' radars due to the strength of its Healthcare arm and strong rebound potential in the AST segment.
Neogen Stock Gains Following Strategic Alliance With Syngenta
NEOG inks a new strategic licensing and supply agreement with Syngenta to market and sell the latter's Talon-G and Talon Weatherblok XT rodenticides in the United States and Canada.
2 Monster Stocks to Hold for the Next 10 Years
Consumer staples companies are often considered safe-haven investments in times of market uncertainty. PepsiCo's stock price has plunged as it faces a weak business outlook, but that could be a buying opportunity. Hershey has suffered from a drastic increase in cocoa prices, but it is still investing for long-term growth.
Deciphering Steris (STE) International Revenue Trends
Examine Steris' (STE) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Veracyte Stock Surges 30.9% in a Year: What's Driving the Rally?
Strength in VCYT's Afirma and Decipher tests continues to draw investors' attention.
Equities Rise Intraday as Markets Weigh Macro Data, Fed Chair's Comments
US benchmark equity indexes were higher intraday as Wall Street parsed latest economic data and rema
STE Q4 Earnings Beat, Margins Expand, Stock Up in Aftermarket
STERIS' fourth-quarter fiscal 2025 results reflect strong growth momentum in Healthcare and AST revenues.
Here's What Key Metrics Tell Us About Steris (STE) Q4 Earnings
Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Steris (STE) Surpasses Q4 Earnings Estimates
Steris (STE) delivered earnings and revenue surprises of 5.79% and 0.09%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: MLAB
STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year
STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year
Full year fiscal 2025 revenue from continuing operations increased 6%; constant currency organic revenue growth was 6% Full year fiscal 2025 as reported...
Is it Worth Retaining Boston Scientific Stock in Your Portfolio Now?
Investors continue to be optimistic about BSX, courtesy of its international expansion efforts and strategic acquisitions.
Nuwellis, Inc. (NUWE) Reports Q1 Loss, Lags Revenue Estimates
Nuwellis (NUWE) delivered earnings and revenue surprises of -53.33% and 23.84%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: NUWE
QIAGEN Stock Gains Following the Acquisition of Genoox
QGEN inks an agreement to acquire Genoox for $70 million in cash. The acquisition expands QIAGEN's QDI portfolio.
What Analyst Projections for Key Metrics Reveal About Steris (STE) Q4 Earnings
Get a deeper insight into the potential performance of Steris (STE) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 21.05% and 6.15%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: PACB
STERIS Declares Dividend of $0.57 per share
STERIS Declares Dividend of $0.57 per share
DUBLIN, IRELAND, May 07, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a...